Arranon (nelarabine) Injection 5mg/mL, 50mL Vials, Rx only, For I.V. Infusion only, GlaxoSmith Kline, Research Triangle Park, NC 27709. Made in England, NDC 0007-4401-06

Class I - Dangerous
💊 Drugs Recalled: October 8, 2012 GlaxoSmithKline Prescription Drugs Nationwide

What Should You Do?

  1. Check if you have this product:
    Lot # C536707 Exp 02/14, C538830 Exp.02/14, C533169 Exp. 02/14
  2. Do not eat it: Even if it looks and smells fine, do not consume this product.
  3. Throw it away or return it: You can return the product to the store for a full refund.
  4. Seek medical attention if needed: If you've consumed this product and feel unwell, contact your doctor immediately.
  5. Report problems: Report any issues to the FDA's Safety Reporting Portal.

⚠️ Emergency: If you experience severe symptoms after consuming this product, call 911 or Poison Control at 1-800-222-1222.

Recall Details

Company:
GlaxoSmithKline, LLC.
Reason for Recall:
Impurities/Degradation Products: Potential for drug related impurities to exceed the specification limits.
Classification:
Class I - Dangerous

Dangerous or defective products that predictably could cause serious health problems or death.

Status:
terminated

Product Information

Full Description:

Arranon (nelarabine) Injection 5mg/mL, 50mL Vials, Rx only, For I.V. Infusion only, GlaxoSmith Kline, Research Triangle Park, NC 27709. Made in England, NDC 0007-4401-06

Product Codes/Lot Numbers:

Lot # C536707 Exp 02/14, C538830 Exp.02/14, C533169 Exp. 02/14

Official Source

Always verify recall information with the official FDA source:

View on FDA.gov

FDA Recall Number: D-068-2013

Related Recalls

Labeling: Incorrect Lot and/or Expiration Date: The carton has incorrect expiration of 2026-MAY*, whereas the correct expiration date, which is on the tablet bottle label, is 2025-APR.

May 17, 2024 Prescription Drugs Nationwide View Details →